Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JORGE BETANCOURT

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1982707998
CMS profile
225893
Location
MIA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$379.13

4 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $379.13 4

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
Siemens Medical Solutions USA, Inc. $156.47 2
Alkermes, Inc. $114.05 1
E.R. Squibb & Sons, L.L.C. $108.61 1

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JORGE BETANCOURT

NPI 1982707998 · CMS profile ID 225893

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

MIA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1982707998?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JORGE BETANCOURT, NPI 1982707998, CMS profile ID 225893. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1982707998?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). JORGE BETANCOURT, NPI 1982707998, CMS profile ID 225893. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1982707998?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
JORGE BETANCOURT, NPI 1982707998, CMS profile ID 225893, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1982707998?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

4 matching records · $379.13 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 4 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–4 of 4.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Siemens Medical Solutions USA, Inc. $24.1105/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 631927257 CMS
Siemens Medical Solutions USA, Inc. $132.3605/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 631927261 CMS
E.R. Squibb & Sons, L.L.C. $108.6104/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651341879 CMS
Alkermes, Inc. $114.0503/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686574955 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $379.13 4
PY2020 $161.80 2
PY2021 $620.46 11
PY2022 $1,100.34 32
PY2023 $35.27 2
PY2024 $216.36 5
PY2025 $19.42 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $1,346,274.20 102
PY2024 Principal investigator $392,078.78 42
PY2023 Principal investigator $8,750.00 1
PY2022 Principal investigator $5,000.00 1
PY2021 Principal investigator $11,250.00 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

102 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $20,718.00 12/25/2025 Non-covered Recipient Entity
NUOVIDA RESEARCH CENTER CORP
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia Symptoms No dispute reported 06/30/2026 1175414594
Principal investigator 1 ACADIA Pharmaceuticals Inc $629.00 12/08/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245938468
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 12/08/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245938470
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 12/08/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245938472
Principal investigator 1 Janssen Research & Development, LLC $42,426.00 12/05/2025 Non-covered Recipient Entity
NUOVIDA RESEARCH CENTER CORP
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia Symptoms No dispute reported 06/30/2026 1175414646
Principal investigator 1 ACADIA Pharmaceuticals Inc $7,579.00 12/03/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245938205
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 11/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245937667
Principal investigator 1 ACADIA Pharmaceuticals Inc $6,005.00 11/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245937669
Principal investigator 1 ACADIA Pharmaceuticals Inc $629.00 11/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245937671
Principal investigator 1 ACADIA Pharmaceuticals Inc $6,005.00 11/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245937673
Principal investigator 1 ACADIA Pharmaceuticals Inc $629.00 11/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245937675
Principal investigator 1 ACADIA Pharmaceuticals Inc $6,005.00 11/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245937677
Principal investigator 1 ACADIA Pharmaceuticals Inc $629.00 11/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245937679
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 11/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245937681
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 11/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245937683
Principal investigator 1 Janssen Research & Development, LLC $42,502.00 11/03/2025 Non-covered Recipient Entity
NUOVIDA RESEARCH CENTER CORP
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia Symptoms No dispute reported 06/30/2026 1175414641
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 10/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245936295
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 10/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245936297
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 10/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245936299
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 10/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245936301
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 10/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245936303
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 10/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245936305
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 10/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245936307
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 10/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245936309
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 10/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245936311
Principal investigator 1 ACADIA Pharmaceuticals Inc $5,389.00 10/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245936313
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 10/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245936315
Principal investigator 1 ACADIA Pharmaceuticals Inc $2,229.00 10/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245937164
Principal investigator 1 Janssen Research & Development, LLC $40,583.00 09/29/2025 Non-covered Recipient Entity
NUOVIDA RESEARCH CENTER CORP
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175414611
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 09/03/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245935785
Principal investigator 1 Janssen Research & Development, LLC $47,061.00 09/01/2025 Non-covered Recipient Entity
NUOVIDA RESEARCH CENTER CORP
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175414651
Principal investigator 1 ACADIA Pharmaceuticals Inc $2,229.00 08/25/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245935693
Principal investigator 1 ACADIA Pharmaceuticals Inc $5,994.00 08/25/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245935695
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,768.00 08/25/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245935697
Principal investigator 1 ACADIA Pharmaceuticals Inc $4,644.00 08/25/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245935699
Principal investigator 1 ACADIA Pharmaceuticals Inc $4,524.00 08/25/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245935701
Principal investigator 1 ACADIA Pharmaceuticals Inc $6,431.00 08/25/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245935703
Principal investigator 1 Janssen Research & Development, LLC $31,269.00 07/31/2025 Non-covered Recipient Entity
NUOVIDA RESEARCH CENTER CORP
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175414630
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 07/25/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245935339
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 07/25/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245935341
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 07/25/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245935343
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 07/25/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245935345
Principal investigator 1 ACADIA Pharmaceuticals Inc $5,389.00 07/25/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245935347
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 07/07/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934837
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 07/07/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934839
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 07/07/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934841
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 07/07/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934843
Principal investigator 1 Janssen Research & Development, LLC $63,588.00 07/07/2025 Non-covered Recipient Entity
NUOVIDA RESEARCH CENTER CORP
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175414665
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $32,193.69 06/25/2025 Non-covered Recipient Entity
Nuovida Research Center Corporation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Agitation Associated with Alzheimers Disease No dispute reported 06/30/2026 1235995103
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $749.34 06/24/2025 Non-covered Recipient Entity
New Life Medical Research Center
Phase III Safety and Efficacy of KarXT in Psychosis Associated with AD (ADEPT 4): 2 of 2 Acute Studies No dispute reported 06/30/2026 1235995383
Principal investigator 1 Janssen Research & Development, LLC $4,897.00 06/09/2025 Non-covered Recipient Entity
NUOVIDA RESEARCH CENTER CORP
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175414606
Principal investigator 1 ACADIA Pharmaceuticals Inc $5,389.00 06/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934283
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 06/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934285
Principal investigator 1 ACADIA Pharmaceuticals Inc $5,389.00 06/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934287
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 06/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934289
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 06/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934291
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 06/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934293
Principal investigator 1 ACADIA Pharmaceuticals Inc $4,586.00 06/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934295
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 06/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934297
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 06/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934299
Principal investigator 1 ACADIA Pharmaceuticals Inc $4,586.00 06/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934301
Principal investigator 1 Janssen Research & Development, LLC $35,516.00 06/02/2025 Non-covered Recipient Entity
NUOVIDA RESEARCH CENTER CORP
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175414617
Principal investigator 1 Janssen Research & Development, LLC $30,000.00 05/20/2025 Non-covered Recipient Entity
NUOVIDA RESEARCH CENTER CORP
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175414660
Principal investigator 1 Janssen Research & Development, LLC $21,906.00 05/15/2025 Non-covered Recipient Entity
NUOVIDA RESEARCH CENTER CORP
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175414589
Principal investigator 1 ACADIA Pharmaceuticals Inc $5,389.00 04/25/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934143
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 04/25/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934145
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 04/25/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934147
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 04/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933991
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 04/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933993
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 04/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933995
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 04/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933997
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,076.00 04/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933999
Principal investigator 1 ACADIA Pharmaceuticals Inc $4,095.00 04/02/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245934001
Principal investigator 1 Janssen Research & Development, LLC $35,041.00 03/31/2025 Non-covered Recipient Entity
NUOVIDA RESEARCH CENTER CORP
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175414634
Principal investigator 1 ACADIA Pharmaceuticals Inc $4,427.00 03/07/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245933819
Principal investigator 1 ACADIA Pharmaceuticals Inc $6,449.00 03/07/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245933821
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 03/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933763
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 03/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933765
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 03/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933767
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 03/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933769
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,166.00 03/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933771
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 03/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933773
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 03/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933775
Principal investigator 1 Janssen Research & Development, LLC $17,297.00 03/03/2025 Non-covered Recipient Entity
NUOVIDA RESEARCH CENTER CORP
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175414599
Principal investigator 1 ACADIA Pharmaceuticals Inc $6,934.00 02/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245933474
Principal investigator 1 ACADIA Pharmaceuticals Inc $6,012.00 02/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245933476
Principal investigator 1 ACADIA Pharmaceuticals Inc $4,122.00 02/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245933478
Principal investigator 1 ACADIA Pharmaceuticals Inc $4,547.00 02/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245933480
Principal investigator 1 ACADIA Pharmaceuticals Inc $4,586.00 02/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933606
Principal investigator 1 ACADIA Pharmaceuticals Inc $4,586.00 02/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933608
Principal investigator 1 ACADIA Pharmaceuticals Inc $4,586.00 02/05/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933610
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $113,578.20 02/05/2025 Non-covered Recipient Entity
Pharmaseek
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimers Disease (ADEPT-4) No dispute reported 06/30/2026 1235994706
Principal investigator 1 Janssen Research & Development, LLC $31,677.00 02/03/2025 Non-covered Recipient Entity
NUOVIDA RESEARCH CENTER CORP
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175414623
Principal investigator 1 ACADIA Pharmaceuticals Inc $4,427.00 01/17/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245933217
Principal investigator 1 ACADIA Pharmaceuticals Inc $6,449.00 01/17/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-006 No dispute reported 06/30/2026 1245933219
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $192,181.21 01/15/2025 Non-covered Recipient Entity
Pharmaseek
A Phase 3, Randomized, Double-blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimers Disease Dementia No dispute reported 06/30/2026 1235994704
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 01/10/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933139
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 01/10/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933141
Principal investigator 1 ACADIA Pharmaceuticals Inc $3,872.00 01/10/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933143
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,076.00 01/10/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933145
Principal investigator 1 ACADIA Pharmaceuticals Inc $4,095.00 01/10/2025 Non-covered Recipient Entity
NEW LIFE MEDICAL RESEARCH CENTER INC
ACP-204-008 No dispute reported 06/30/2026 1245933147
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $281,939.76 01/03/2025 Non-covered Recipient Entity
Pharmaseek
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects with Psychosis Associated with Alzheimers Disease Dementia No dispute reported 06/30/2026 1235994702